Source: PRNewswire DUBLIN, March 26, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced it has completed the…...
Latest News
Biofrontera, Inc., USA, acquires Cutanea Life Sciences, Inc., USA
Source: GlobeNewswire Leverkusen, Germany, March 25, 2019 (GLOBE NEWSWIRE) -- Biofrontera Inc., USA (“Biofrontera”), a wholly owned subsidiary of Biofrontera…...
Stryker acquires OrthoSpace and its rotator cuff implant in $220M deal
Source: FierceBiotech Stryker has acquired OrthoSpace, developers of a therapy for severely torn rotator cuffs, in a deal worth up…...
Sun Pharmaceutical Industries Inc. Announces Plans to Present 19 Data Abstracts on ILUMYA™ for Moderate-to-Severe Plaque Psoriasis at American Academy of Dermatology 2019 Annual Meeting
Source: PR Newswire PRINCETON, N.J., Feb. 27, 2019 /PRNewswire/ -- Sun Pharmaceutical Industries Inc., USA (SPII) today announced that it plans to present 19 abstracts…...
FDA approves Medtronic device for sealing off deeper, smaller brain aneurysms
Source: FierceBiotech Medtronic has received approval of an expanded indication from the FDA for its Pipeline Flex embolization device, for…...
Anthem moves up launch of its PBM to second quarter of 2019
Source: FierceHealthcare Anthem is planning to begin moving members into its new PBM, IngenioRx, in the second quarter of 2019,…...
Bristol-Myers Squibb to Acquire Celgene to Create a Premier Innovative Biopharma Company
Source: BusinessWire Bristol-Myers Squibb Company (NYSE:BMY) and Celgene Corporation (NASDAQ:CELG) today announced that they have entered into a definitive merger…...
Sienna Biopharmaceuticals Announces Its Topical, Non-Steroidal TRKA Inhibitor SNA-120 (0.05%) Demonstrated Significant Impact on Psoriasis in Phase 2B Study and Plans to Initiate Phase 3 Psoriasis Trials in Second Half of 2019
Source: Sienna Biopharmaceuticals WESTLAKE VILLAGE, Calif., Dec. 03, 2018 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA), a clinical-stage medical dermatology and aesthetics company, today…...
Telehealth firm 98point6 nets $50M in round led by Goldman Sachs
Source: FierceBiotech 98point6, a digital health company that makes primary care doctors available to patients over cellphone messages, raised $50…...
Sanofi, Regeneron score positive Dupixent data in sinusitis as they await key FDA asthma verdict
Source: FiercePharma As the FDA gets set to decide whether Sanofi and Regeneron’s atopic dermatitis drug, Dupixent, can make a…...